subsidiary for Quarter 1 of 2020 ending on 31 March 2020 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical treatment for the 1st
shareholders on the basis of outstanding stock held by them when the merged CCPH’s surplus profits exceeds 100% of its capital stock. Provided that the rate of https://market.sec.or.th/public/idisc/Download
summarized as follows: Consolidated FS Quarter 1/2019 Quarter 1/2020 Change MB. % MB. % MB. % Revenue from contracts with customers 1,943.6 70.9% 1,714.0 64.3% -229.6 -11.8% Interest income from loans from the
49.34 17.69% Finance cost 49.11 68.10 18.99 38.67% Income tax expenses 48.04 57.52 9.48 19.73% Net profit 181.71 202.58 20.87 11.49% Net profit ratio (ROS) 17.16% 15.74% Earnings per share (Baht) 0.34
Leases Operating Cost (Exclude D&A) Single Expense EBITDA D&A Depreciation Operating Profits Finance Cost Interest EBT Asset Liabilities Off Balance sheet rights /obligations Soon to be opened Postponed
%) Loss from impairment (611) (2,619) - - (611) (2,619) 2,008 77% Profit (Loss) before the effects of foreign exchange, deferred income tax and lease income 9,715 20,507 42 246 9,757 20,753 (10,996) (53
Flow Hedges, only the effective portion of changes in the fair value of the derivatives is recognized in other comprehensive income. Any ineffective portion is recognized immediately in profit or loss
recently established on 19 December 2017 which has yet to operate and so generating no commercial income; it has been viewed, therefore, that the purchase price is the reasonable purchase price. In addition
expenses, thus the increased rate of profits higher than the increase rate of revenue. When compare to the profit of Q1–2021 and Q4–2020, it found that the decreased rate in revenue of 11.9% but the -2